These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35059121)

  • 41. Artemisinin Cocrystals for Bioavailability Enhancement. Part 1: Formulation Design and Role of the Polymeric Excipient.
    Kaur M; Yardley V; Wang K; Masania J; Botana A; Arroo RRJ; Li M
    Mol Pharm; 2021 Dec; 18(12):4256-4271. PubMed ID: 34723557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein.
    Pi J; Wang S; Li W; Kebebe D; Zhang Y; Zhang B; Qi D; Guo P; Li N; Liu Z
    Asian J Pharm Sci; 2019 Mar; 14(2):154-164. PubMed ID: 32104447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation of Polymorphism and Cocrystallization of Active Pharmaceutical Ingredients Using Vibrational Spectroscopic Techniques.
    Du Y; Xue J
    Curr Pharm Des; 2016; 22(32):4917-4928. PubMed ID: 27464725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.
    Al-Kazemi R; Al-Basarah Y; Nada A
    Adv Pharm Bull; 2019 Oct; 9(4):559-570. PubMed ID: 31857959
    [No Abstract]   [Full Text] [Related]  

  • 45. Cocrystal Construction Between Rosuvastatin Calcium and L-asparagine with Enhanced Solubility and Dissolution Rate.
    Vemuri VD; Lankalapalli S
    Turk J Pharm Sci; 2021 Dec; 18(6):790-798. PubMed ID: 34979738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmaceutical cocrystals: walking the talk.
    Bolla G; Nangia A
    Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Daidzein cocrystals: An opportunity to improve its biopharmaceutical parameters.
    Bhalla Y; Chadha K; Chadha R; Karan M
    Heliyon; 2019 Nov; 5(11):e02669. PubMed ID: 31763466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations.
    Wan M; Fang J; Xue J; Liu J; Qin J; Hong Z; Li J; Du Y
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals.
    Healy AM; Worku ZA; Kumar D; Madi AM
    Adv Drug Deliv Rev; 2017 Aug; 117():25-46. PubMed ID: 28342786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissolution Advantage of Nitazoxanide Cocrystals in the Presence of Cellulosic Polymers.
    Salas-Zúñiga R; Rodríguez-Ruiz C; Höpfl H; Morales-Rojas H; Sánchez-Guadarrama O; Rodríguez-Cuamatzi P; Herrera-Ruiz D
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31881696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
    Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
    Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
    Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
    Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations.
    Uppoor VR
    J Control Release; 2001 May; 72(1-3):127-32. PubMed ID: 11389991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Understanding
    B Shekhawat P; B Pokharkar V
    Acta Pharm Sin B; 2017 May; 7(3):260-280. PubMed ID: 28540164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.
    Panzade PS; Shendarkar GR
    Curr Drug Deliv; 2017; 14(8):1097-1105. PubMed ID: 27758692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioavailability of indomethacin-saccharin cocrystals.
    Jung MS; Kim JS; Kim MS; Alhalaweh A; Cho W; Hwang SJ; Velaga SP
    J Pharm Pharmacol; 2010 Nov; 62(11):1560-8. PubMed ID: 21039541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.
    Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S
    Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structures, dissolution and pharmacokinetic study on a novel phosphodiesterase-4 inhibitor chlorbipram cocrystals.
    Zhou J; Li L; Zhang H; Xu J; Huang D; Gong N; Han W; Yang X; Zhou Z
    Int J Pharm; 2020 Feb; 576():118984. PubMed ID: 31870960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design.
    Berry DJ; Steed JW
    Adv Drug Deliv Rev; 2017 Aug; 117():3-24. PubMed ID: 28344021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics.
    Shan N; Perry ML; Weyna DR; Zaworotko MJ
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1255-71. PubMed ID: 25089559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.